lemtrada 10 mg/ml solution à diluer pour perfusion
sanofi-aventis (suisse) sa - alemtuzumabum - solution à diluer pour perfusion - alemtuzumabum 12 mg, dinatrii edetas, kalii chloridum, kalii dihydrogenophosphas, natrii chloridum, dinatrii phosphas dihydricus, polysorbatum 80, aqua ad iniectabile ad solutionem pro 1.2 ml corresp. natrium 4.26 mg et kalium 0.19 mg. - sclérose en plaques - biotechnologika
lemtrada solution
sanofi genzyme, a division of sanofi-aventis canada inc - alemtuzumab - solution - 12mg - alemtuzumab 12mg - antineoplastic agents
tachosil timbre
corza medical gmbh - thrombine (humaine); collagène; fibrinogène (humaine) - timbre - 2unité; 2.1mg; 5.5mg - thrombine (humaine) 2unité; collagène 2.1mg; fibrinogène (humaine) 5.5mg - hemostatics
tachosil timbre
corza medical gmbh - fibrinogène (humaine); thrombine (humaine); collagène - timbre - 5.5mg; 2unité; 2.1mg - fibrinogène (humaine) 5.5mg; thrombine (humaine) 2unité; collagène 2.1mg - hemostatics
octalbin 25% solution
octapharma pharmazeutika produktionsges m b h - albumine (humaine) - solution - 25% - albumine (humaine) 25% - blood derivatives
alburex - 5 solution
csl behring canada inc - albumine (humaine) - solution - 5% - albumine (humaine) 5% - blood derivatives
alburex - 25 solution
csl behring canada inc - albumine (humaine) - solution - 25% - albumine (humaine) 25% - blood derivatives
octalbin 5% solution
octapharma pharmazeutika produktionsges m b h - albumine (humaine) - solution - 5% - albumine (humaine) 5% - blood derivatives
evicel solution
omrix biopharmaceuticals ltd - fibrinogène (humaine); thrombine (humaine) - solution - 90mg; 1200unité - fibrinogène (humaine) 90mg; thrombine (humaine) 1200unité - hemostatics
tachosil timbre
corza medical gmbh - thrombine (humaine); collagène; fibrinogène (humaine) - timbre - 2unité; 2.1mg; 5.5mg - thrombine (humaine) 2unité; collagène 2.1mg; fibrinogène (humaine) 5.5mg - hemostatics